Eisai’s Leqembi Wins Coverage from US Veteran’s Body

March 15, 2023
Eisai said on March 14 that the US Veterans’ Health Administration (VHA) has started providing coverage for its Alzheimer’s treatment Leqembi (lecanemab) for veterans living with early stages of the disease. The coverage comes two months after the drug grabbed...read more